Since the objectives of this Regulation, namely the harmonised monitoring of the trade in drug precursors and the avoidance of its diversion to the illicit manufacture of synthetic drugs and psychotropic substances, cannot be sufficiently achieved by the Member States and can therefore, by reason of the international and changeable nature of such trade, be better achieved at Community level, the Community may adopt measures, in accordance with the principle of subsidiarity as set out in Article 5 of the Treaty. In accordance with the principle of proportionality, as set out in that Article, this Regulation does not go beyond what is necessary in order to achieve those objectives.
Recital 17, Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February…
In forcesince 11 Feb 2004cited 2×
Judgment of the Court (Fifth Chamber) of 12 February 2015. N.F. Gielen and Others.Decision
This request for a preliminary ruling concerns the interpretation of Article 2(a), (b), (d) and (f) of Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004 on drug precursors (OJ 2004 L 47, p. 1) …
12 Feb 2015 · 62013CJ0369
Judgment of the Court (Seventh Chamber) of 2 February 2023. Criminal proceedings against TF.Decision
Next, recitals 3, 6 and 17 of Regulation No 273/2004 make reference to a system for monitoring the ‘trade’ in drug precursors and recitals 5 and 11 thereof state, respectively, the need ‘to detect possible cases of illicit diversion …
2 Feb 2023 · 62021CJ0806